Ginkgo Bioworks Acquires Proof Diagnostics
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
📰 Sid Shenai News
Sid Shenai News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sid Shenai. Real-time updates on events, politics, business and more.
Ginkgo Bioworks Acquires Proof Diagnostics, Growing Gene Editing Service Offerings for its Customers
BOSTON, Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, announced the acquisition of Proof Diagnostics, an...
Source: marketscreener.com
With COVID-19 Response Evolving, Next-Gen Dx Technologies Face Uncertain Future
COVID-19 drove an investment boom that pushed diagnostics innovation, but newer technologies could be in a precarious position as public funding and test sales slow.
Source: 360dx.com
Beyond COVID-19, Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
Proof Diagnostics recently submitted a CRISPR-based, point-of-care test for SARS-COV-2 to the US Food and Drug Administration for Emergency Use Authorization.
Source: 360dx.com
PROOF DIAGNOSTICS SUBMITS REQUEST FOR EMERGENCY USE AUTHORIZATION SEEKING FIRST APPROVAL OF CRISPR-BASED MOLECULAR POINT-OF-CARE COVID-19 TEST
/PRNewswire/ -- Proof Diagnostics, Inc., an innovative healthcare technology company delivering innovative solutions in molecular diagnostics, today announced...
Source: prnewswire.com